Scarborough Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-608
Closed -$32.4K 390
2026
Q1
$32.4K Buy
+608
New +$35.7K ﹤0.01% 282
2024
Q1
Sell
-1,438
Closed -$77.6K 532
2023
Q4
$77.6K Buy
+1,438
New +$70.2K 0.02% 130
2022
Q4
Sell
-29,317
Closed -$1.38M 58
2022
Q3
$1.38M Sell
29,317
-12
-0% -$623 0.43% 41
2022
Q2
$1.48M Sell
29,329
-15,934
-35% -$868K 0.5% 37
2022
Q1
$2.76M Buy
45,263
+3,933
+10% +$234K 0.88% 29
2021
Q4
$2.72M Buy
+41,330
New +$2.65M 0.94% 29

Other funds holding IHI

Scarborough Advisors's IHI Position: Q2 2026 in Review

Scarborough Advisors sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 608 shares — an estimated $32.4K sold.

Scarborough Advisors first reported a position in IHI in Q4 2021 and held it in 6 quarters. The position peaked at $2.76M in Q1 2022. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Scarborough Advisors reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 608 iShares US Medical Devices ETF shares in Q2 2026, an estimated $32.4K.
  • Scarborough Advisors first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 6 quarters.
  • Scarborough Advisors's iShares US Medical Devices ETF position peaked at $2.76M in Q1 2022.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.